You have 9 free searches left this month | for more free features.

leukemia

Showing 1 - 25 of 7,852

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

CLL, SLL, HCL Trial in Dresden

Recruiting
  • CLL
  • +7 more
    • Dresden, Sachsen, Germany
      BAG Freiberg-Richter, Jacobasch, Wolf, Illmer
    Apr 29, 2022

    Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in

    Completed
    • Recurrent Acute Leukemia of Ambiguous Lineage
    • +5 more
    • Chemosensitivity Assay
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jun 29, 2022

    Philadelphia Chromosome, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Suzhou (Azacitidine, Venetoclax,

    Recruiting
    • Philadelphia Chromosome
    • +4 more
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Jun 23, 2022

    Acute Myeloid Leukemia (AML) Trial in Charlotte (Allogeneic HCT, Consolidation chemo)

    Terminated
    • Acute Myeloid Leukemia (AML)
    • Allogeneic HCT
    • Consolidation chemotherapy
    • Charlotte, North Carolina
      Levine Cancer Institute
    Apr 19, 2022

    Recurrent Acute Myeloid Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia Trial

    Not yet recruiting
    • Recurrent Acute Myeloid Leukemia
    • +7 more
    • Anti-CD123 ADC IMGN632
    • +7 more
    • (no location specified)
    Jun 28, 2022

    Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) Trial in Guediawaye GOL SUD (Pyronaridine Tetraphosphate)

    Not yet recruiting
    • Acute Myeloid Leukemia (AML)
    • Acute Lymphoblastic Leukemia (ALL)
    • Pyronaridine Tetraphosphate
    • Guediawaye GOL SUD, Dakar, Senegal
      Dalal Jamm Hospital
    Jul 21, 2022

    National Center for Precision Medicine in Leukemia

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +4 more
    • Biobanking
    • (no location specified)
    Jun 7, 2022

    Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti-siglec-6 CAR-T cell therapy)

    Recruiting
    • Acute Myeloid Leukemia Refractory
    • Acute Myeloid Leukemia, in Relapse
    • anti-siglec-6 CAR-T cell therapy
    • Xuzhou, Jiangsu, China
      Kailin Xu
    Aug 2, 2022

    Higher Risk Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial (AMG 176, Azacitidine)

    Not yet recruiting
    • Higher Risk Myelodysplastic Syndrome
    • Chronic Myelomonocytic Leukemia
    • (no location specified)
    Jul 29, 2022

    Acute Myeloid Leukemia Patients on Correlation to CD200 and CD56

    Not yet recruiting
    • Acute Myeloid Leukemia
    • bone marrow aspirate and biopsy
    • (no location specified)
    Aug 20, 2022

    ITGA4 Gene Methylation Status in Chronic Lymphocytic Leukemia

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
      • (no location specified)
      May 7, 2022

      Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Miami (Total Body Irradiation (TBI), Thiotepa, Cyclophosphamide)

      Not yet recruiting
      • Leukemia, Myeloid, Acute
      • Leukemia, Lymphocytic, Acute
      • Total Body Irradiation (TBI)
      • +5 more
      • Miami, Florida
        Baptist Health South Florida/Miami Cancer Institute
      Sep 30, 2022

      Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse Trial in Miami (Bomedemstat,

      Not yet recruiting
      • Acute Myeloid Leukemia
      • +2 more
      • Miami, Florida
        University of Miami
      Oct 24, 2022

      MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial (RP7214)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • +2 more
      • (no location specified)
      Aug 17, 2022

      Impact of Optical Genome Mapping in Acute Myeloblastic Leukemia

      Not yet recruiting
      • Acute Myeloblastic Leukemia
        • (no location specified)
        Aug 10, 2022

        FoxO3a and PU.1 in Acute Lymphoblastic Leukemia

        Not yet recruiting
        • Acute Lymphoblastic Leukemia
        • complete blood count
        • (no location specified)
        Feb 15, 2022

        Large Granular Lymphocyte Leukemia Trial in Tampa (Siltuximab)

        Recruiting
        • Large Granular Lymphocyte Leukemia
        • Tampa, Florida
          Moffitt Cancer Center
        Mar 30, 2022

        Leukemia, T Cell Trial in Beijing (CD7 CART)

        Recruiting
        • Leukemia, T Cell
        • CD7 CART
        • Beijing, Hebei, China
          He bei Yan da Lu dao pei Hospital
        May 24, 2022

        Acute Myeloid Leukemia Trial (CIML-NK Cells)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • CIML-NK Cells
        • (no location specified)
        Oct 12, 2022

        Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia Recurrent Trial (CD123-CAR-NK cells)

        Not yet recruiting
        • Acute Myeloid Leukemia Refractory
        • Acute Myeloid Leukemia Recurrent
        • CD123-CAR-NK cells
        • (no location specified)
        Oct 7, 2022

        Acute Lymphoblastic Leukemia, Leukemia Trial in Houston (Ponatinib, Venetoclax, Mini-hyper CVD)

        Recruiting
        • Acute Lymphoblastic Leukemia
        • Leukemia
        • Houston, Texas
          MD Anderson Cancer Center
        Aug 23, 2022

        B-cell Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia

        Recruiting
        • B-cell Acute Lymphoblastic Leukemia
        • +2 more
        • Milwaukee, Wisconsin
          Medical College of Wisconsin
        Apr 4, 2022

        Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia

        Recruiting
        • Chronic Lymphocytic Leukemia
        • +4 more
          • Bobigny, France
          • +8 more
          Mar 23, 2022

          Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in Oklahoma City, Houston (Fenretinide,

          Terminated
          • Acute Myelogenous Leukemia
          • +2 more
          • Oklahoma City, Oklahoma
          • +1 more
          Mar 17, 2022